The FDA has even authorized a drug designed with cannabidiol for that reason (Epidiolex). Though the company only recommends it for 2 rare types of childhood epilepsy called Lennox-Gastaut syndrome and Dravet syndrome.Presented these associated genetic and environmental vulnerabilities, supplemental knowledge from potential, longitudinal investigat